12-month trajectories of anxiety symptoms and functional recovery after new-onset stroke: A multicenter prospective cohort study- commentary on our paper

Commentary: Poststroke anxiety trajectories—important signal, but causality and clinical thresholds need clarification Commentary on: “Two distinct 12-month poststroke anxiety symptom trajectories…” (prospective multicenter cohort; HAMA-14; latent class growth modeling/growth mixture modeling; mRS outcome) Overview This study addresses an important and Read More …

12-month trajectories of anxiety symptoms and functional recovery after new-onset stroke: A multicenter prospective cohort study

Highlights Abstract Background The longitudinal course of poststroke anxiety remains poorly characterized. This study aimed to delineate the trajectories of anxiety symptoms within 12 months post-stroke and evaluate their associations with functional recovery. Methods This prospective multicenter cohort study enrolled patients Read More …

Tardive Dyskinesia Development, Superoxide Dismutase Levels,and Relevant Genetic Polymorphisms- suggestions for further studies

Tardive dyskinesia (TD)—a common movement disorder affecting people with schizophrenia after long-term antipsychotic use—may be linked to inherited differences in oxidative-stress and dopamine-related genes, according to a new review. The findings suggest that variants in superoxide dismutase (SOD), the dopamine Read More …

Beyond Paranoia: Neuropsychological and Biological Correlates of Cognitive Heterogeneity in Schizophrenia Subtypes

The paper aims to move “beyond paranoia”—that is, beyond the traditional focus on positive symptoms like delusions—to examine the neuropsychological and biological factors that drive cognitive heterogeneity within schizophrenia subtypes. The central premise is that schizophrenia is not a single Read More …